Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Micelle Technology is a Swiss private company focused on micelle-based delivery technology designed to improve the oral bioavailability of poorly absorbed natural compounds. Its proprietary MyCell Technology uses a micellization process intended to mimic the body's handling of fat-soluble substances and enable more efficient absorption in nutraceutical and health-related products. The company appears to operate primarily as a platform and formulation business rather than a traditional therapeutic drug developer with a disclosed clinical pipeline. Publicly available materials emphasize commercial applications in high-bioavailability natural products rather than named prescription drug candidates in clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Micelle Technology.